Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Accenture
Merck
Boehringer Ingelheim
Cantor Fitzgerald
Fish and Richardson
AstraZeneca
Chinese Patent Office
Baxter

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022052

« Back to Dashboard

NDA 022052 describes ZYFLO CR, which is a drug marketed by Chiesi Usa Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the ZYFLO CR profile page.

The generic ingredient in ZYFLO CR is zileuton. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the zileuton profile page.
Summary for 022052
Tradename:ZYFLO CR
Applicant:Chiesi Usa Inc
Ingredient:zileuton
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 022052
Mechanism of Action5-Lipoxygenase Inhibitors
Physiological EffectDecreased Leukotriene Production
Suppliers and Packaging for NDA: 022052
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052 NDA Chiesi USA, Inc. 10122-902 N 10122-902-20
ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052 NDA Chiesi USA, Inc. 10122-902 N 10122-902-12

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength600MG
Approval Date:May 30, 2007TE:ABRLD:Yes

Expired US Patents for NDA 022052

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 ➤ Sign Up ➤ Sign Up
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 ➤ Sign Up ➤ Sign Up
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Chubb
Queensland Health
Fuji
Accenture
Moodys
Citi
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot